ACLY and CKD: A Mendelian Randomization Analysis

Pedrum Mohammadi-Shemirani1,2,3, Michael Chong1,2,3, Nicolas Perrot1

  • 1Department of Biomarkers and Genetics, Population Health Research Institute, Hamilton, Ontario, Canada.

Abstract

Insights

Adenosine triphosphate-citrate lyase (ACLY) inhibition may reduce chronic kidney disease (CKD) risk. Genetically reduced ACLY expression was linked to a lower CKD risk, but not estimated glomerular filtration rate or albumin-to-creatinine ratio.

Area of Science:

  • Biochemistry
  • Genetics
  • Nephrology

Background:

  • Adenosine triphosphate-citrate lyase (ACLY) is a therapeutic target for metabolic diseases.
  • ACLY inhibition shows potential in reducing inflammation and kidney fibrosis in mouse models.
  • Genetic analysis of ACLY in chronic kidney disease (CKD) has been lacking.

Purpose of the Study:

  • To investigate the effect of genetically predicted Adenosine triphosphate-citrate lyase (ACLY) expression on the risk of chronic kidney disease (CKD).
  • To evaluate the association between ACLY expression and kidney function markers, including estimated glomerular filtration rate (eGFR) and albumin-to-creatinine ratio (ACR).

Main Methods:

  • Constructed a genetic instrument for ACLY expression using 13 variants from the eQTLGen consortium.
  • Performed a 2-sample Mendelian randomization analysis using data from CKDGen, UK Biobank, and FinnGen.
  • Evaluated the effect of genetically predicted ACLY expression on CKD risk, eGFR, and ACR in 66,396 CKD cases and 958,517 controls.

Main Results:

  • Genetically reduced ACLY expression was associated with a 9% reduced risk of CKD.
  • A 34% reduction in ACLY expression score correlated with lower LDL cholesterol.
  • No significant association was found between genetically reduced ACLY expression and eGFR or ACR.

Conclusions:

  • Genetically reduced Adenosine triphosphate-citrate lyase (ACLY) expression is associated with a decreased risk of chronic kidney disease (CKD).
  • ACLY does not appear to influence estimated glomerular filtration rate (eGFR) or albumin-to-creatinine ratio (ACR).
  • Further research into ACLY's role in kidney disease is warranted.

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.1K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
85
Determination of Renal Drug Clearance: Graphical and Midpoint Methods01:07

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
194
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
Chi-square Analysis02:46

Chi-square Analysis

The chi-square test is a statistical hypothesis test. It is used to check whether there is a significant difference between an expected value and an observed value. In the context of genetics, it enables us to either accept or reject a hypothesis, based on how much the observed values deviate from the expected values.
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
38.7K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
56